All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
WASHINGTON – Small biotechs waiting for Congress to breathe new life into the Small Business Innovation Research (SBIR) program will have to wait a little longer.
